Physiological and pathological roles of the accommodation response in lower esophageal sphincter relaxation during wet swallows.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 04 2021
Historique:
received: 16 08 2020
accepted: 16 03 2021
entrez: 13 4 2021
pubmed: 14 4 2021
medline: 4 11 2021
Statut: epublish

Résumé

The preparatory accommodation response of lower esophageal sphincter (LES) before swallowing is one of the mechanisms involved in LES relaxation during wet swallows, however, the physiological and/or pathological roles of LES accommodation remain to be determined in humans. To address this problem, we conducted a prospective observational study of 38 patients with normal high-resolution manometry (HRM) and 23 patients with idiopathic esophagogastric junction outflow obstruction (EGJOO) to assess dry and wet swallows. The LES accommodation measurement was proposed for practical use in evaluating the LES accommodation response. Although swallow-induced LES relaxation was observed in both dry and wet swallows, LES accommodation (6.4, 3.1-11.1 mmHg) was only observed in wet swallows. The extent of LES accommodation was impaired in idiopathic EGJOO (0.6, - 0.6-6 mmHg), and the LES accommodation measurement of patients with idiopathic EGJOO (36.8, 29.5-44.3 mmHg) was significantly higher in comparison to those with normal HRM (23.8, 18-28.6 mmHg). Successful LES relaxation in wet swallowing can be achieved by LES accommodation in combination with swallow-induced LES relaxation. Impaired LES accommodation is characteristic of idiopathic EGJOO. In addition to the IRP value, the LES accommodation measurement may be useful for evaluating the LES relaxation function in clinical practice.

Identifiants

pubmed: 33846463
doi: 10.1038/s41598-021-87052-x
pii: 10.1038/s41598-021-87052-x
pmc: PMC8042112
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7898

Références

Neurogastroenterol Motil. 2015 Feb;27(2):160-74
pubmed: 25469569
Endosc Int Open. 2018 Aug;6(8):E1031-E1036
pubmed: 30105290
Clin Gastroenterol Hepatol. 2018 Nov;16(11):1692-1700
pubmed: 29702296
Gastroenterology. 2017 Nov;153(5):1205-1211
pubmed: 28989059
Surg Endosc. 2017 May;31(5):2187-2201
pubmed: 27633440
Am J Physiol. 1998 Nov;275(5):G1127-36
pubmed: 9815043
Neurogastroenterol Motil. 2017 Jun;29(6):
pubmed: 28393437
Neurogastroenterol Motil. 2011 Sep;23(9):819-30
pubmed: 21711416
Neurogastroenterol Motil. 2017 Oct;29(10):1-9
pubmed: 28544670
Expert Opin Investig Drugs. 2011 May;20(5):701-12
pubmed: 21417958
Gastroenterology. 1995 Feb;108(2):441-6
pubmed: 7835586
Dig Endosc. 2018 Sep;30(5):563-579
pubmed: 30022514
Neurogastroenterol Motil. 2012 Jun;24(6):540-5, e250-1
pubmed: 22385472
J Smooth Muscle Res. 1997 Jun;33(3):81-8
pubmed: 9533819
Clin Gastroenterol Hepatol. 2016 Jun;14(6):907-911
pubmed: 26792374
Digestion. 1997;58(3):232-9
pubmed: 9243118
J Gastrointest Surg. 2009 Dec;13(12):2219-25
pubmed: 19672666
Am J Physiol Gastrointest Liver Physiol. 2003 Feb;284(2):G242-7
pubmed: 12388187
Am J Physiol Gastrointest Liver Physiol. 2012 Mar 1;302(5):G542-7
pubmed: 22173917
Am J Physiol. 1997 Feb;272(2 Pt 1):G265-71
pubmed: 9124350
Gastroenterology. 2013 Nov;145(5):954-65
pubmed: 23973923
Am J Gastroenterol. 2015 Jul;110(7):979-84
pubmed: 26032150
Digestion. 2016;94(1):9-16
pubmed: 27326454

Auteurs

Kazumasa Muta (K)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, Japan.

Eikichi Ihara (E)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, Japan. eikichi@intmed3.med.kyushu-u.ac.jp.
Department of Gastroenterology and Metabolism, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, 812-8582, Japan. eikichi@intmed3.med.kyushu-u.ac.jp.

Shohei Hamada (S)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, Japan.

Hiroko Ikeda (H)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, Japan.

Masafumi Wada (M)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, Japan.

Yoshitaka Hata (Y)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, Japan.

Xiaopeng Bai (X)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, Japan.

Yuichiro Nishihara (Y)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, Japan.

Yoshimasa Tanaka (Y)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, Japan.

Haruei Ogino (H)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, Japan.

Yoshihiro Ogawa (Y)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH